{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:21:37Z","timestamp":1779211297867,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10620-024-08784-0","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T11:23:44Z","timestamp":1734089024000},"page":"526-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integration of Non-invasive Screening for Cystic Fibrosis Related Liver Disease in the Regular Follow-Up for Cystic Fibrosis"],"prefix":"10.1007","volume":"70","author":[{"given":"Diana","family":"Coman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Bilodeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Brochiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Hercun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"8784_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/MCP.0b013e3282f10a16","volume":"13","author":"C Colombo","year":"2007","unstructured":"Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med. 2007;13:529\u2013536.","journal-title":"Curr Opin Pulm Med."},{"key":"8784_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jcf.2022.07.017","volume":"22","author":"DH Leung","year":"2022","unstructured":"Leung DH, Ye W, Schwarzenberg SJ, Freeman AJ, et al. Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study. J Cyst Fibros. 2022;22:248\u2013255.","journal-title":"J Cyst Fibros."},{"key":"8784_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/hep.29217","volume":"66","author":"C Koh","year":"2017","unstructured":"Koh C, Sakiani S, Surana P, et al. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity. Hepatology. 2017;66:591\u2013601.","journal-title":"Hepatology."},{"key":"8784_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3138\/canlivj-2018-0019","volume":"2","author":"J Hercun","year":"2019","unstructured":"Hercun J, Alvarez F, Vincent C, Bilodeau M. Cystic fibrosis liver disease: A condition in need of structured transition and continuity of care. Canadian Liver Journal. 2019;2:71\u201383.","journal-title":"Canadian Liver Journal."},{"key":"8784_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jhep.2021.09.042","volume":"76","author":"J Dana","year":"2022","unstructured":"Dana J, Debray D, Beaufrere A, et al. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies. J Hepatol. 2022;76:420\u2013434.","journal-title":"J Hepatol."},{"key":"8784_CR6","first-page":"136","volume":"9","author":"N Kobelska-Dubiel","year":"2014","unstructured":"Kobelska-Dubiel N, Klincewicz B, Cichy W. Liver disease in cystic fibrosis. Prz Gastroenterol. 2014;9:136\u2013141.","journal-title":"Prz Gastroenterol."},{"key":"8784_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jcf.2020.05.002","volume":"19","author":"W Karnsakul","year":"2020","unstructured":"Karnsakul W, Wasuwanich P, Ingviya T, et al. A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease. J Cyst Fibros. 2020;19:546\u2013552.","journal-title":"J Cyst Fibros."},{"key":"8784_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","volume":"12","author":"T Flass","year":"2013","unstructured":"Flass T, Narkewicz MR. Cirrhosis and other liver disease in cystic fibrosis. J Cyst Fibros. 2013;12:116\u2013124.","journal-title":"J Cyst Fibros."},{"key":"8784_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcf.2016.08.002","volume":"16","author":"SA Woodruff","year":"2017","unstructured":"Woodruff SA, Sontag MK, Accurso FJ, Sokol RJ, Narkewicz MR. Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen. J Cyst Fibros. 2017;16:139\u2013145.","journal-title":"J Cyst Fibros."},{"key":"8784_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/MPG.0000000000000758","volume":"61","author":"FA Bodewes","year":"2015","unstructured":"Bodewes FA, van der Doef HP, Houwen RH, Verkade HJ. Increase of serum gamma-glutamyltransferase associated with development of cirrhotic cystic fibrosis liver disease. J Pediatr Gastroenterol Nutr. 2015;61:113\u2013118.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"8784_CR11","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/hep.28016","volume":"62","author":"DH Leung","year":"2015","unstructured":"Leung DH, Khan M, Minard CG, et al. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology. 2015;62:1576\u20131583.","journal-title":"Hepatology."},{"key":"8784_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/imj.12707","volume":"45","author":"T Jong","year":"2015","unstructured":"Jong T, Geake J, Yerkovich S, Bell SC. Idiosyncratic reactions are the most common cause of abnormal liver function tests in patients with cystic fibrosis. Intern Med J. 2015;45:395\u2013401.","journal-title":"Intern Med J."},{"key":"8784_CR13","doi-asserted-by":"crossref","unstructured":"Palaniappan SK, Than NN, Thein AW, Moe S, van Mourik I. Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database Syst Rev. 2017;8:CD012056.","DOI":"10.1002\/14651858.CD012056.pub2"},{"key":"8784_CR14","doi-asserted-by":"publisher","first-page":"12198","DOI":"10.1038\/s41598-024-62549-3","volume":"14","author":"D Ouzan","year":"2024","unstructured":"Ouzan D, Penaranda G, Jlaiel M, Joly H, Corneille J. Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver disease. Scientific Reports. 2024;14:12198.","journal-title":"Scientific Reports."},{"key":"8784_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2020.11.050","volume":"74","author":"M Papatheodoridi","year":"2021","unstructured":"Papatheodoridi M, Hiriart JB, Lupsor-Platon M, et al. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. J Hepatol. 2021;74:1109\u20131116.","journal-title":"J Hepatol."},{"key":"8784_CR16","unstructured":"Kemp W. RS. FibroScan\u00ae and transient elastography. Australian Family Physician. 2013;42."},{"key":"8784_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1155\/2015\/138530","volume":"29","author":"MD Sadler","year":"2015","unstructured":"Sadler MD, Crotty P, Fatovich L, Wilson S, Rabin HR, Myers RP. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis. Can J Gastroenterol Hepatol. 2015;29:139\u2013144.","journal-title":"Can J Gastroenterol Hepatol."},{"key":"8784_CR18","unstructured":"Cystic Fibrosis Foundation Patient Registry 2021 Annual Data Report. 2021."},{"key":"8784_CR19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/liv.12113","volume":"33","author":"MT Kitson","year":"2013","unstructured":"Kitson MT, Kemp WW, Iser DM, Paul E, Wilson JW, Roberts SK. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease. Liver Int. 2013;33:698\u2013705.","journal-title":"Liver Int."},{"key":"8784_CR20","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1111\/liv.15748","volume":"43","author":"E Dajti","year":"2023","unstructured":"Dajti E, Ravaioli F, Paiola G, et al. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study. Liver Int. 2023;43:2492\u20132502.","journal-title":"Liver Int."},{"key":"8784_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","volume":"79","author":"ZM Sellers","year":"2024","unstructured":"Sellers ZM, Assis DN, Paranjape SM, et al. Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations. Hepatology. 2024;79:1220\u20131238.","journal-title":"Hepatology."},{"key":"8784_CR22","doi-asserted-by":"crossref","unstructured":"Ayoub F. T-AC, Morelli G., Lascano J. Risk factors for hepatic steatosis in adults with cystic fibrosis- Similarities to non-alcoholic fatty liver disease. World Journal of Hepatology 2018;10:34\u201340.","DOI":"10.4254\/wjh.v10.i1.34"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08784-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:41:31Z","timestamp":1739990491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08784-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["8784"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08784-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}